Systematic SARS-CoV-2-testing for asymptomatic cancer patients treated at a public healthcare tertiary centre in Brazil

BACKGROUND: The coronavirus disease (COVID-19) pandemic has had enormous consequences in Brazil and worldwide. Patients with cancer affected by COVID-19 are at a higher risk of developing complications and worse outcomes compared to the non-cancer population, particularly the ones on active systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fares, Aline F, Fadul, Luiza A, Benetton, Barbara, Nogueira, Mauricio L, Lanza, Marcia, Araújo, Daniel V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426015/
https://www.ncbi.nlm.nih.gov/pubmed/34567254
http://dx.doi.org/10.3332/ecancer.2021.1269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426015/
https://www.ncbi.nlm.nih.gov/pubmed/34567254
http://dx.doi.org/10.3332/ecancer.2021.1269

Ejemplares similares